ラマト・ガンで最高の治療科医師 - トップ8名の医師

Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.

• Served as the Head of the Hematology Division at Tel Aviv University.
• Treats complex cases of leukemia, lymphoma, and rare pediatric cancers.
• Member of the American Society of Hematology and European Group for Blood and Marrow Transplantation.
• Collaborates on research with the NIH and St. Jude Children’s Research Hospital.

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.

• Authored over 25 peer-reviewed publications on tumor biology and new treatments.
• Serves as an investigator for the National Cancer Institute (NCI) programs.
• Manages metastatic disease using precision diagnostics and specialized biomarkers.
• Member of the Israel Society of Oncology and Radiotherapy.

Dr. Amit Tirosh is the Head of the Neuroendocrine Tumors (NET) Service at Sheba Medical Center. He is an international authority on von Hippel–Lindau (VHL) disease and hereditary tumor syndromes. Dr. Tirosh contributed to global clinical guidelines for VHL management. He also leads the Endocrine Oncology Bioinformatics Lab at Sheba.

• Contributor to the international expert panel on VHL management guidelines.
• Authored over 40 peer-reviewed papers in journals like JAMA and Gastroentrology.
• Maintains research affiliations with the NIH and the Weizmann Institute.
• Performs specialized NET treatments, including Lutetium-177 therapy and PRRT.

Dr. Zvi Cohen is the Director of the Neurosurgery Department at Sheba Medical Center. He was recently recognized in Forbes Israel’s Best Doctors list for 2025. Dr. Cohen specializes in treating complex brain, pituitary, and spinal cord tumors. He founded the brain tumor tissue bank at Sheba to support oncological research. Dr. Cohen is board-certified in neurosurgery and leads clinical trials for malignant brain tumors.

• Completed fellowships in neurosurgical oncology at MD Anderson and neuroradiology at Beth Israel.
• Expert in intraoperative MRI, stereotactic biopsies, and image-guided resections.
• Performs radiosurgery and minimally invasive microsurgery for CNS tumors.
• Member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. David Mishaali is the Director of Pediatric and Congenital Cardiothoracic Surgery at Sheba Medical Center. He specializes in treating infants and children with high-risk heart anomalies. Dr. Mishaali developed a unique minimally invasive surgical approach for congenital heart defects. He works at Sheba Medical Center, a hospital ranked among the world’s top 10.

• Completed fellowships at the Cleveland Clinic and UCSF in the USA.
• Treats rare newborn conditions requiring complex cardiac reconstruction.
• Uses minimally invasive methods to reduce trauma and improve cosmetic results.
• Senior Lecturer and author of numerous peer-reviewed papers on cardiac surgery.

Dr. Boaz Liberman is the Director of the Orthopedic Oncology Unit at Sheba Medical Center. He specializes in treating bone and soft tissue sarcomas in adults and children. Dr. Liberman was recognized in the Forbes list of top doctors in Israel. He focuses on limb-sparing cancer surgery combined with functional reconstruction. Dr. Liberman completed fellowships at Mount Sinai Hospital and Princess Margaret Cancer Centre in Toronto.

• Performs complex joint reconstruction and revision hip or knee replacements.
• Uses MRgFUS to treat bone conditions with imaging-guided ultrasound.
• Treats childhood tumors like Ewing's sarcoma and rhabdomyosarcoma.
• Member of the American and European Associations of Tissue Banks.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.